Norddeutsche Landesbank disclosed Evonik Industries (ETR:EVK), boosting its price target to 28.00EUR earlier today
- Updated: November 29, 2016
Reporting a potential upside of 0.08%, Norddeutsche Landesbank upped the price target of Evonik Industries (ETR:EVK) to 28.00EUR
On 11/21/2016, Kepler Cheuvreux released a statement about Evonik Industries (ETR:EVK) upped the target price from 0.00EUR to 23.00EUR that suggested a downside of -0.12%.
Having a price of 25.93EUR, Evonik Industries (ETR:EVK) traded 2.38% higher on the day. With the last stock price up -2.21% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.03% over the same period. EVK has recorded a 50-day average of 2.28EUR and a two hundred day average of 2.20EUR. Volume of trade was down over the average, with 206 shares of EVK changing hands under the typical 3,925
See Chart Below
Evonik Industries has a 52 week low of 1.35EUR and a 52 week high of 3.02EUR with a P/E ratio of 3.92 The company’s market cap is currently 0 EUR.
General Information About Evonik Industries (ETR:EVK)
Evonik Industries AG (Evonik) is a Germany-based company engaged in the specialty chemicals sector. The Company's activities are divided in four segments: Nutrition & Care, produces specialty chemicals, mainly for use in consumer goods for daily needs and food, as well as in animal nutrition and healthcare products; Resource Efficiency, offers material solutions for environment-friendly and energy-efficient products used in the automotive, adhesives and construction industries, among others; Performance Materials, produces polymer materials and their intermediates, mainly for the rubber, plastics and agriculture sectors, and Services, includes site management, utilities and waste management, as well as technical, process technology, engineering and logistics services for the chemicals segments and external customers at Company's sites, among others. It is a subsidiary of RAG Stiftung.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.